There was no significant difference between the ETV group (66 patients) and the TAF group (11 patients) with regard to age, sex, hepatitis B status, genotype, HBV DNA, ALT, HBeAg status, HBsAg titer, eGFR, original diseases, and purpose of treatment. This evidence concerns the gene GPT and hepatitis B virus infection.